Inflanor 20 mg/ml oral suspension 100 ml
Inflanor 20 mg/ml oral suspension 100 ml
Inflanor 20 mg/ml oral suspension 100 ml
Inflanor is intended for the short-term treatment of symptoms: Mild to moderate pain (headache, sore throat, toothache, pain when sprained or bruised), fevers (including post-vaccination fever, i.e. fever after vaccination) and febrile states in influenza and colds. Inflanor contains the medicine ibuprofen, which belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). These products work by changing the body's response to pain and increased temperature. Due to the dosage form, Inflanor 20 mg/ml is primarily intended for children with a body weight of 5 kg (3 months and above). The package contains 100 ml.
Dosage and method of use
The dose of ibuprofen in children and adolescents depends on the body weight and age of the patient. For infants and children from 3 months to 12 years, the usual daily dose is 20-30 mg/kg, which is administered in 3-4 sub-doses, with a dosing interval of 6-8 hours.1.
Mild to moderate pain and feverish conditions with flu and colds:
Recommended dosage of Inflanor 20 mg/ml according to the child's body weight and age:
Body weight (approximate age) Single dose Frequency of administration per 24 hours Maximum daily dose5-6 kg (3-6 months) 2.5 ml (50 mg ibuprofen) 3 times 7.5 ml (150 mg ibuprofen)7-9 kg (7-12 months) 2,5 ml (50 mg ibuprofen) 3 to 4 times 10 ml (200 mg ibuprofen)10-15 kg (1-3 years) 5 ml (100 mg ibuprofen) 3 times 15 ml (300 mg ibuprofen)16-19 kg (4-6 years) 7,5 ml (150 mg ibuprofen) 3 times 22,5 ml (450 mg ibuprofen)20-29 kg (7-9 years) 10 ml (200 mg ibuprofen) 3 times 30 ml (600 mg ibuprofen)30-39 kg (10-12 years) 10 ml (200 mg ibuprofen) 3 to 4 times 40 ml (800 mg ibuprofen)
2. Dosage for fever following vaccination (children aged 3-6 months):
In case of fever after vaccination, 2.5 ml of suspension can be given. If the fever does not subside, a further 2.5 ml of the suspension can be given after 6 hours. If the fever does not go down even after the second dose, do not administer the next dose and consult your doctor for further action.
Contraindications
The product is not intended for paediatric patients with a body weight of less than 5 kg.
Notice
Consult your doctor or pharmacist before taking Inflanor if your child:
I have an infectious disease - see the heading Infections below; - has certain inherited hematopoietic disorders (e.g. acute intermittent porphyria); - suffer from blood clotting disorders; - has a serious immune system disease affecting connective tissue (systemic lupus erythematosus (SLE) or mixed connective tissue disease); - has or has ever had a bowel disease (ulcerative colitis or Crohn's disease), as these diseases can get worse; - has or has ever had high blood pressure and/or heart failure; - has mild or moderate hepatic or renal impairment; - concomitant use of other medicines that could increase the risk of ulcers or bleeding, such as orally administered corticosteroids (such as prednisolone), blood thinners (such as warfarin), selective serotonin reuptake inhibitors (medicines to treat depression) or blood thinners (such as acetylsalicylic acid). - is taking another NSAID (including the so-called. selective cyclooxygenase-2 inhibitors such as celecoxib or etoricoxib), as concomitant use of these drugs should be avoided; - has or has had asthma or allergic disease, as they may experience shortness of breath; - suffer from hay fever, nasal polyps or chronic obstructive pulmonary disease, as in such cases there is an increased risk of allergic reactions; these can manifest as asthma attacks (called. analgesic asthma), Quincke's edema or urticaria; - has just undergone major surgery because medical supervision may be needed; - is dehydrated, as dehydrated children are at increased risk of kidney dysfunction; - had an allergic reaction to any substances, as in this case there is an increased risk of an allergic reaction to Inflanor as well.
Symptoms of an allergic reaction to ibuprofen have been reported, including breathing difficulties, swelling of the face and throat (angioedema) and chest pain. If you experience any of these symptoms, stop using Inflanor immediately and contact your doctor or a medical emergency room without delay.
Storage
Keep this product out of sight and reach of children. Store at temperatures up to 25 °C. Do not use this product after the expiry date stated on the box and bottle after EXP. The expiry date shall be the last day of the month indicated.
Shelf life after first opening the bottle:
1 year.
Do not dispose of any medicines in wastewater or household waste. Ask your pharmacist how to dispose of products you no longer use. These measures help protect the environment.
Specifications
Active ingredient
Category
Form
Usage
Packaging
Storage temperature
Identifiers
Pharmacotherapeutic group
Product characteristics
| Code: | SPToth555 |
| Warranty: | 24 months |